Product Program year 2019 Source: CMS Open Payments

narsoplimab

Drug Immunology

Open in the dashboard

General payments

$84,617

185 payments

Research payments

$0

0 payments

Through program year 2019, $84,617 in general payments and $0 in research payments were reported against narsoplimab (Immunology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2019 General $84,617 185

Breakdown

Who paid General payments · program year 2019
  1. Omeros Corporation $84,617 185 payments
Top recipients General payments · program year 2019
  1. Miguel Perales Medical Oncology · New York, NY $8,293 10% · 15 payments
  2. Samer Khaled Hematology & Oncology · Orlando, FL $6,768 8% · 14 payments
  3. Richard Champlin Hematology & Oncology · Houston, TX $6,690 8% · 16 payments
  4. Sayed Mehdi Hamadani Hematology & Oncology · Milwaukee, WI $6,447 8% · 13 payments
  5. Vincent Ho Medical Oncology · Boston, MA $6,302 7% · 19 payments

The top 5 of 22 recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Hematology & Oncology Internal Medicine $37,724 51% · 9 practitioners
  2. Medical Oncology Internal Medicine $17,593 24% · 3 practitioners
  3. Pediatric Hematology-Oncology Pediatrics $5,809 8% · 3 practitioners
  4. General Practice $3,639 5% · 1 practitioner
  5. Obstetrics & Gynecology $3,590 5% · 1 practitioner

The top 5 of 7 specialties; each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2019
  1. Massachusetts $19,683 23% · 4 recipients
  2. Texas $12,528 15% · 2 recipients
  3. New York $9,808 12% · 6 recipients
  4. California $9,729 11% · 2 recipients
  5. Wisconsin $6,447 8% · 1 recipient

The top 5 of 12 states; each share is of general payments naming this product in 2019 where a state was reported.

The top 25 states, free in the app

185 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record